SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-23-000087
Filing Date
2023-11-07
Accepted
2023-11-07 08:30:50
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20230930.htm   iXBRL 10-Q 1256049
2 EX-10.2 rahacooemploymentagreement.htm EX-10.2 71141
3 EX-31.1 exhibit311-certificationof.htm EX-31.1 10441
4 EX-31.2 exhibit312-certificationof.htm EX-31.2 10442
5 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6112
  Complete submission text file 0000899923-23-000087.txt   7746245

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20230930.xsd EX-101.SCH 55010
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20230930_cal.xml EX-101.CAL 89042
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20230930_def.xml EX-101.DEF 246098
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20230930_lab.xml EX-101.LAB 770558
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20230930_pre.xml EX-101.PRE 490046
88 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20230930_htm.xml XML 1134320
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 231381812
SIC: 2835 In Vitro & In Vivo Diagnostic Substances